AI assistant
My Size, Inc. — Director's Dealing 2020
Jun 8, 2020
35445_dirs_2020-06-08_5f3fe838-a47f-4c61-a55c-0c7de47cc0dd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: My Size, Inc. (MYSZ)
CIK: 0001211805
Period of Report: 2020-05-25
Reporting Person: Braniztky Oron (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-05-25 | Option to purchase Common Stock (right to buy) | $18.15 | D | 667 | Disposed | 2022-07-24 | Common Stock, $.001 par value per share (667) | Direct |
| 2020-05-25 | Option to purchase Common Stock (right to buy) | $1.04 | A | 667 | Acquired | 2023-07-24 | Common Stock, $.001 par value per share (667) | Direct |
| 2020-05-25 | Option to purchase Common Stock (right to buy) | $13.65 | D | 667 | Disposed | 2023-09-06 | Common Stock, $.001 par value per share (667) | Direct |
| 2020-05-25 | Option to purchase Common Stock (right to buy) | $1.04 | A | 667 | Acquired | 2024-09-06 | Common Stock, $.001 par value per share (667) | Direct |
| 2020-05-25 | Option to purchase Common Stock (right to buy) | $11.4 | D | 1000 | Disposed | 2024-05-29 | Common Stock, $.001 par value per share (1000) | Direct |
| 2020-05-25 | Option to purchase Common Stock (right to buy) | $1.04 | A | 1000 | Acquired | 2025-05-29 | Common Stock, $.001 par value per share (1000) | Direct |
Footnotes
F1: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested.
F2: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of July 24, 2023. All of the other terms of the option remained unchanged.
F3: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of September 6, 2024. All of the other terms of the option remained unchanged.
F4: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged.